의료용 가구 시장 예측(-2031년) : 제품·서비스별, 용도별, 최종사용자별, 지역별

The global medical furniture market is projected to reach USD 18.21 billion by 2031 from USD 14.02 billion in 2026, at a CAGR of 5.4% during the forecast period.

The medical furniture market is driven by expanding healthcare infrastructure, rising hospitalization rates, increasing chronic disease burden, and growing demand for advanced, ergonomic, and patient-centric care environments across hospitals, ASCs, and long-term care facilities. Government investments in modernization and the shift toward smart, digitally integrated furniture further accelerate adoption. However, market expansion is restrained by high capital costs, budget constraints in public and emerging-market hospitals, long replacement cycles, infrastructural incompatibilities in older facilities, and the availability of low-cost local alternatives, which collectively slow procurement and upgrade decisions.

"By products & services segment, the chairs & seating segment is projected to grow at the fastest CAGR in the medical furniture market during the forecast period."

By products & services segment, the market is divided into medical beds, chairs & seatings, tables, stretchers, trolleys & carts, cabinets, storage units, lockers, services, and others. Among these, the chairs & segment sub-segment is projected to grow at the fastest CAGR during the forecast period, owing to rising surgical volumes, expanding diagnostic procedures, and increasing investments in operating room modernization. The tables segment is further bifurcated into general surgery operating tables, orthopedic tables, gynecology/obstetric tables, imaging tables, examination tables, and other tables. Growth across these sub-segments is supported by the increasing prevalence of chronic diseases, higher demand for minimally invasive surgeries, and expansion of specialty care services. Technological advancements such as motorized positioning, radiolucent surfaces, imaging compatibility, and modular designs are enhancing product value and driving replacement demand. Additionally, growing ambulatory surgery centers and diagnostic facilities are accelerating procurement of advanced tables. As hospitals upgrade infrastructure to improve procedural efficiency and patient safety, demand for specialized and multi-functional tables is expected to expand significantly.

"By end user, the ambulatory surgery centers segment accounted for the second largest share in the medical furniture market in 2025."

By end users, the medical furniture market is divided into hospitals, clinics, ambulatory surgery centers, long-term & nursing facilities, and other end users. Among these, in 2025, the ambulatory surgery centers (ASCs) segment held the second largest share in the market. This is driven by lower procedure costs, reduced hospital stays, and improved reimbursement incentives. ASCs are rapidly expanding across developed and emerging markets, requiring substantial investments in specialized medical furniture, including operating tables, procedure chairs, stretchers, cabinets, and recovery beds. Increasing adoption of minimally invasive and elective procedures further boosts demand for high-performance, compact, and workflow-optimized furniture. Additionally, private equity investment in ASC networks and the preference for decentralized care support continuous capacity expansion, positioning ASCs as the fastest-growing end-user segment.

"The Asia Pacific region segment is projected to grow at the fastest CAGR in the medical furniture market during the forecast period."

The medical furniture market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

The Asia Pacific region is estimated to grow at the fastest CAGR due to substantial healthcare expansion, rapid demographic aging, and rising healthcare spending across major economies. India's healthcare sector is growing at an exceptional pace, projected to reach USD 638 billion by 2025, supported by increasing investments in hospitals, diagnostics, and specialty care, which accelerates demand for medical beds, stretchers, tables, and patient-care furniture. Japan, one of the world's oldest nations, spends USD 5,251 per capita on health, 11.5% of its GDP, driving continuous upgrades in acute, geriatric, and long-term care facilities. China's aging population of 216.76 million people aged 65+ is intensifying the need for rehabilitation centers, nursing care, and hospital capacity expansion. Additionally, Asia Pacific countries are rapidly modernizing their healthcare infrastructure and witnessing rising insurance penetration and medical tourism. Together, these developments make Asia Pacific the fastest-growing region for medical furniture during the forecast period.

A breakdown of the primary participants (supply-side) for the medical furniture market referred to in this report is provided below:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level - 50%, Director Level - 30%, and Others - 20%
• By Region: North America - 30%, Europe - 25%, Asia Pacific - 20%, Latin America - 15%, Middle East & Africa - 10%

Prominent players in the medical furniture market: Arjo (Sweden), Getinge AB (Sweden), Baxter (US), Stryker (US), PARAMOUNT BED CO., LTD. (Japan), GPC Medical Ltd (India), MillerKnoll, Inc. (US), KOVONAX spol. s r.o. (Czech Republic), Drive DeVilbiss Healthcare (US), LINET Group SE (Netherlands), Joerns Healthcare (US), Stiegelmeyer GmbH & Co. KG (Germany), Steris Corporation (US), Savaria (Canada), PROMOTAL (France), Skytron, LLC (US), GF Health Products, Inc. (US), Midmark Corporation (US), Opera Beds (UK), medifa (Germany), Malvestio Spa (Italy), Merivaara Corp (Finland), Amico Group of Companies (Canada), Narang Medical Limited (India), and Umano Medical Inc. (Canada).

Research Coverage

The report analyzes the medical furniture market and aims to estimate the market size and future growth potential of this market based on various segments such as products & services, application, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall medical furniture market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (rising burden of chronic diseases & increasing hospitalization rates, aging population driving long-term and geriatric care needs, and government initiatives for healthcare modernization), restraints (high cost of advanced medical furniture & long product life cycle leading to slow replacement rate), opportunities (rising need for bariatric care furniture), and challenges (limited customization and low premium product adoption is challenging the medical furniture market growth)
• Market Penetration: It includes extensive information on products offered by the major players in the global medical furniture market. The report consists of various segments in products & services, applications, end users, and regions.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global medical furniture market
• Market Development: Thorough knowledge and analysis of the profitable rising markets by products & services, application, end user, and region
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global medical furniture market
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global medical furniture market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 VENTURE CAPITALISTS EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: INSIGHTS AND DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING MARKET
• 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 MEDICAL FURNITURE MARKET OVERVIEW
• 3.2 NORTH AMERICA: MEDICAL FURNITURE MARKET, BY END USER
• 3.3 GEOGRAPHIC SNAPSHOT OF MEDICAL FURNITURE MARKET (2025)
• 3.4 GEOGRAPHIC MIX: MEDICAL FURNITURE MARKET, 2026-2031 (USD MILLION)
• 3.5 MEDICAL FURNITURE MARKET: DEVELOPING VS. DEVELOPED MARKETS, 2026 VS. 2031 (USD MILLION)

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Rising chronic disease burden and hospital admissions
    • 4.2.1.2 Aging population drives demand for long-term care medical furniture
    • 4.2.1.3 Rising government healthcare investments
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 High capital costs and long replacement cycles
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Rising obesity prevalence to drive demand for specialized bariatric medical furniture
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Limited customization and low-premium product adoption
• 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.3.1 UNMET NEEDS IN MEDICAL FURNITURE MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 BARGAINING POWER OF SUPPLIERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC OUTLOOK
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS AND FORECAST
  • 5.2.3 TRENDS IN GLOBAL DURABLE MEDICAL EQUIPMENT INDUSTRY
  • 5.2.4 TRENDS IN MEDICAL FACILITY PRODUCTS INDUSTRY
• 5.3 REIMBURSEMENT ANALYSIS
• 5.4 SUPPLY CHAIN ANALYSIS
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 PRICING ANALYSIS (2023-2025)
  • 5.7.1 AVERAGE SELLING PRICE TREND, BY PRODUCT (2023-2025)
  • 5.7.2 AVERAGE SELLING PRICE TREND, BY REGION (2023-2025)
• 5.8 TRADE ANALYSIS
  • 5.8.1 IMPORT SCENARIO (HS CODE 9402)
  • 5.8.2 EXPORT DATA (HS CODE 9402)
• 5.9 KEY CONFERENCES AND EVENTS, 2026-2027
• 5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.11 INVESTMENT AND FUNDING SCENARIO
• 5.12 IMPACT OF 2025 US TARIFF - MEDICAL FURNITURE MARKET
  • 5.12.1 INTRODUCTION
  • 5.12.2 KEY TARIFF RATES
  • 5.12.3 PRICE IMPACT ANALYSIS
  • 5.12.4 IMPACT ON COUNTRIES/REGIONS
    • 5.12.4.1 North America
    • 5.12.4.2 Europe
    • 5.12.4.3 Asia Pacific
  • 5.12.5 END-USE INDUSTRY IMPACT

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 ELECTROMECHANICAL ACTUATION SYSTEMS
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 IOT AND REMOTE MONITORING INTEGRATION
• 6.3 TECHNOLOGY/PRODUCT ROADMAP
  • 6.3.1 SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
  • 6.3.2 MID-TERM (2027-2031) | EXPANSION & STANDARDIZATION
  • 6.3.3 LONG-TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
• 6.4 PATENT ANALYSIS
  • 6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 6.5 FUTURE APPLICATIONS
  • 6.5.1 AI-ENABLED SMART ICU BEDS
  • 6.5.2 CONNECTED & INTEROPERABLE HOSPITAL FURNITURE
• 6.6 IMPACT OF AI/GEN AI ON MEDICAL FURNITURE MARKET
  • 6.6.1 TOP USE CASES AND MARKET POTENTIAL
  • 6.6.2 BEST OPERATIONAL PRACTICES IN MEDICAL FURNITURE MARKET
  • 6.6.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL FURNITURE MARKET
  • 6.6.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • 6.6.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN POWERED MEDICAL FURNITURE MARKET

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 INDUSTRY STANDARDS
• 7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
• 7.3 US MEDICAL FURNITURE HCPCS CODING LANDSCAPE
  • 7.3.1 HCPCS CODE ARCHITECTURE AND SEGMENT CONCENTRATION
  • 7.3.2 CLAIMS-BASED DEMAND ANALYSIS AND VOLUME STABILITY
  • 7.3.3 COMPETITIVE BIDDING AND PRICING PRESSURE ANALYSIS
  • 7.3.4 STRATEGIC INSIGHTS AND CONCLUSION
• 7.4 PURCHASING MODEL
  • 7.4.1 PROVIDERS PURCHASING MEDICAL FURNITURE
  • 7.4.2 PURCHASING BEHAVIOR

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 STAKEHOLDERS AND BUYING CRITERIA
  • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.2.2 KEY BUYING CRITERIA
• 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
• 8.5 MARKET PROFITABILITY
  • 8.5.1 REVENUE POTENTIAL
  • 8.5.2 COST DYNAMICS
  • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 MEDICAL FURNITURE MARKET, BY PRODUCT & SERVICE

• 9.1 INTRODUCTION
• 9.2 MEDICAL BEDS
  • 9.2.1 BY PRODUCT
    • 9.2.1.1 Electric beds
      • 9.2.1.1.1 Electric beds to dominate medical beds segment
    • 9.2.1.2 Semi-electric beds
      • 9.2.1.2.1 Cost-performance advantage accelerates adoption
    • 9.2.1.3 Manual beds
      • 9.2.1.3.1 Cost-effective infrastructure expansion to drive demand
  • 9.2.2 BY TYPE
    • 9.2.2.1 Critical care beds
      • 9.2.2.1.1 Increasing prevalence of chronic diseases to drive segmental growth
    • 9.2.2.2 Long-term & home care beds
      • 9.2.2.2.1 Rising long-term diseases to drive growth
    • 9.2.2.3 Maternity & pediatric beds
      • 9.2.2.3.1 Expanding maternal and neonatal care infrastructure to drive segment
    • 9.2.2.4 General ward beds
      • 9.2.2.4.1 High inpatient volumes driving sustained demand for general ward beds
    • 9.2.2.5 Other beds
• 9.3 CHAIRS & SEATING
  • 9.3.1 GYNECOLOGY/OB-GYN CHAIRS
    • 9.3.1.1 Rising women's preventive healthcare drives demand
  • 9.3.2 DIALYSIS CHAIRS
    • 9.3.2.1 Rising incidence of chronic kidney disease drives demand
  • 9.3.3 BARIATRIC CHAIRS
    • 9.3.3.1 Rising global obesity rates drive demand
  • 9.3.4 OTHER CHAIRS
• 9.4 TABLES
  • 9.4.1 GENERAL SURGERY OPERATING TABLES
    • 9.4.1.1 High surgical volumes drive demand
  • 9.4.2 GYNECOLOGY/OBSTETRIC TABLES
    • 9.4.2.1 Continuous childbirth volumes and reproductive care to drive demand
  • 9.4.3 ORTHOPEDIC TABLES
    • 9.4.3.1 Rising musculoskeletal disorders and joint replacements to drive demand
  • 9.4.4 EXAMINATION TABLES
    • 9.4.4.1 High outpatient volumes sustain demand
  • 9.4.5 IMAGING TABLES
    • 9.4.5.1 Rising diagnostic imaging volumes to drive demand
  • 9.4.6 OTHER TABLES
• 9.5 STRETCHERS
  • 9.5.1 EMERGENCY STRETCHERS
    • 9.5.1.1 Rising emergency admissions and trauma cases to drive demand
  • 9.5.2 SPECIALTY STRETCHERS
    • 9.5.2.1 Procedure-specific clinical needs to drive demand
  • 9.5.3 TRANSFER & PROCEDURE TROLLEYS
    • 9.5.3.1 Expanding ambulatory surgeries to accelerate demand
• 9.6 CABINETS, LOCKERS, AND STORAGE UNITS
  • 9.6.1 BEDSIDE & WARD STORAGE
    • 9.6.1.1 Universal inpatient deployment to drive segment
  • 9.6.2 CLINICAL STORAGE
    • 9.6.2.1 Regulatory compliance and infection control to drive demand
  • 9.6.3 PERSONAL & STAFF STORAGE
    • 9.6.3.1 Expanding healthcare workforce and hygiene protocols to drive segment
  • 9.6.4 OTHER CABINETS, LOCKERS, AND STORAGE UNITS
• 9.7 TROLLEYS & CARTS
  • 9.7.1 INSTRUMENT TROLLEYS
    • 9.7.1.1 Essential surgical workflow requirements to drive segmental growth
  • 9.7.2 LOGISTIC & UTILITY CARTS
    • 9.7.2.1 Increasing hospital throughput to drive demand
  • 9.7.3 ANESTHESIA CARTS
    • 9.7.3.1 Rising surgical procedures and medication safety to drive segment growth
  • 9.7.4 OTHER TROLLEYS & CARTS
• 9.8 SERVICES
  • 9.8.1 MAINTENANCE & ANNUAL MAINTENANCE CONTRACTS
    • 9.8.1.1 Growing installed base of powered furniture drives segment dominance
  • 9.8.2 INSTALLATION & COMMISSIONING
    • 9.8.2.1 Expanding healthcare infrastructure to drive demand
  • 9.8.3 OTHER SERVICES
• 9.9 OTHER PRODUCTS

10 MEDICAL FURNITURE MARKET, BY APPLICATION

• 10.1 INTRODUCTION
• 10.2 PATIENT CARE & ACCOMMODATION
  • 10.2.1 LARGE BASE OF INSTALLED BEDS TO DRIVE SEGMENT
• 10.3 CRITICAL CARE FACILITIES
  • 10.3.1 RISING CHRONIC DISEASE PREVALENCE TO DRIVE SEGMENT GROWTH
• 10.4 LONG-TERM & BARIATRIC CARE
  • 10.4.1 RISING LONG-TERM DISEASES TO DRIVE DEMAND
• 10.5 MATERNITY & PEDIATRICS
  • 10.5.1 SUSTAINED CHILDBIRTH RATES DRIVE DEMAND
• 10.6 OTHER APPLICATIONS

11 MEDICAL FURNITURE MARKET, BY END USER

• 11.1 INTRODUCTION
• 11.2 HOSPITALS
  • 11.2.1 PRIVATE HOSPITALS
    • 11.2.1.1 Higher capital spending drives private hospital segment
  • 11.2.2 PUBLIC HOSPITALS
    • 11.2.2.1 Extensive patient coverage sustains demand in public hospitals
• 11.3 AMBULATORY SURGERY CENTERS
  • 11.3.1 SHIFT TOWARD OUTPATIENT SURGERIES DRIVES SEGMENT GROWTH
• 11.4 LONG-TERM & NURSING FACILITIES
  • 11.4.1 RISING PREVALENCE OF LONG-TERM DISEASES & AGING POPULATION BURDEN TO DRIVE SEGMENTAL GROWTH
• 11.5 CLINICS
  • 11.5.1 EXPANDING OUTPATIENT SERVICES TO DRIVE GROWTH
• 11.6 OTHER END USERS

12 MEDICAL FURNITURE MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 12.2.2 US
    • 12.2.2.1 US to dominate North American market during forecast period
  • 12.2.3 CANADA
    • 12.2.3.1 Growth in disabled population to fuel medical furniture market
• 12.3 EUROPE
  • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 12.3.2 GERMANY
    • 12.3.2.1 Dominant European medical furniture market
  • 12.3.3 UK
    • 12.3.3.1 Rising government investment in hospital infrastructure to drive market
  • 12.3.4 FRANCE
    • 12.3.4.1 High healthcare expenditure and government investment foster rapid market growth
  • 12.3.5 ITALY
    • 12.3.5.1 Rapidly aging population and rising injury rates to drive market
  • 12.3.6 SPAIN
    • 12.3.6.1 Growing disability prevalence and mobility challenges increases demand for patient handling equipment
  • 12.3.7 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 12.4.2 CHINA
    • 12.4.2.1 China to dominate regional market during forecast period
  • 12.4.3 JAPAN
    • 12.4.3.1 Rapidly aging population and expanding healthcare infrastructure drives market expansion
  • 12.4.4 INDIA
    • 12.4.4.1 Sustained, broad-based growth driven by growing hospital infrastructure and demand for long-term care
  • 12.4.5 AUSTRALIA
    • 12.4.5.1 Intensive hospital utilization set to drive demand across care settings
  • 12.4.6 SOUTH KOREA
    • 12.4.6.1 Increasing investment in hospital equipment to drive market growth
  • 12.4.7 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 12.5.2 BRAZIL
    • 12.5.2.1 Expanding hospital network, dual public-private coverage, and rising chronic disease burden to drive market
  • 12.5.3 MEXICO
    • 12.5.3.1 Rising obesity rates and associated hospitalization needs to propel market growth
  • 12.5.4 REST OF LATIN AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 12.6.2 GCC COUNTRIES
    • 12.6.2.1 Expanding hospital capacity and smart hospital investments to accelerate medical furniture demand
  • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

• 13.1 INTRODUCTION
• 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL FURNITURE MARKET
• 13.3 REVENUE ANALYSIS, 2021-2025
• 13.4 MARKET SHARE ANALYSIS, 2025
• 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 13.5.5.1 Company footprint
    • 13.5.5.2 Region footprint
    • 13.5.5.3 Product & service footprint
    • 13.5.5.4 Application footprint
    • 13.5.5.5 End user footprint
• 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 RESPONSIVE COMPANIES
  • 13.6.3 DYNAMIC COMPANIES
  • 13.6.4 STARTING BLOCKS
  • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
    • 13.6.5.1 Detailed list of key startups/SMEs
    • 13.6.5.2 Competitive benchmarking of key startups/SMEs
• 13.7 COMPANY VALUATION & FINANCIAL METRICS
  • 13.7.1 FINANCIAL METRICS
  • 13.7.2 COMPANY VALUATION
• 13.8 BRAND/PRODUCT COMPARISON
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 PRODUCT LAUNCHES & APPROVALS
  • 13.9.2 DEALS
  • 13.9.3 EXPANSIONS
  • 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 ARJO
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Product launches & approvals
      • 14.1.1.3.2 Other developments
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Right to win
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses & competitive threats
  • 14.1.2 GETINGE AB
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Product launches & approvals
      • 14.1.2.3.2 Deals
      • 14.1.2.3.3 Expansions
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Right to win
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses & competitive threats
  • 14.1.3 BAXTER
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Product launches & approvals
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Right to win
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses & competitive threats
  • 14.1.4 STRYKER CORPORATION
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Product launches & approvals
    • 14.1.4.4 MnM view
      • 14.1.4.4.1 Right to win
      • 14.1.4.4.2 Strategic choices
      • 14.1.4.4.3 Weaknesses & competitive threats
  • 14.1.5 PARAMOUNT BED HOLDINGS CO., LTD.
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Product launches & approvals
    • 14.1.5.4 MnM view
      • 14.1.5.4.1 Right to win
      • 14.1.5.4.2 Strategic choices
      • 14.1.5.4.3 Weaknesses & competitive threats
  • 14.1.6 STERIS
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products offered
  • 14.1.7 MILLERKNOLL, INC.
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Product launches & approvals
  • 14.1.8 SAVARIA
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products offered
  • 14.1.9 LINET
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products offered
    • 14.1.9.3 Recent developments
      • 14.1.9.3.1 Product launches & approvals
      • 14.1.9.3.2 Deals
      • 14.1.9.3.3 Expansions
  • 14.1.10 DRIVE DEVILBISS HEALTHCARE
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products offered
    • 14.1.10.3 Recent developments
      • 14.1.10.3.1 Other developments
  • 14.1.11 JOERNS HEALTHCARE
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products offered
    • 14.1.11.3 Recent developments
      • 14.1.11.3.1 Product launches & approvals
  • 14.1.12 STIEGELMEYER GMBH & CO. KG
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products offered
  • 14.1.13 MALVESTIO SPA
    • 14.1.13.1 Business overview
    • 14.1.13.2 Products offered
• 14.2 OTHER PLAYERS
  • 14.2.1 NARANG MEDICAL LIMITED
  • 14.2.2 GF HEALTH PRODUCTS, INC.
  • 14.2.3 PROMOTAL
  • 14.2.4 GPC MEDICAL LTD
  • 14.2.5 KOVONAX SPOL. S R.O.
  • 14.2.6 SKYTRON LLC
  • 14.2.7 MIDMARK CORPORATION
  • 14.2.8 MEDIFA
  • 14.2.9 MERIVAARA CORP.
  • 14.2.10 AMICO GROUP OF COMPANIES.
  • 14.2.11 UMANO MEDICAL INC
  • 14.2.12 OPERA BEDS

15 RESEARCH METHODOLOGY

• 15.1 RESEARCH DATA
  • 15.1.1 SECONDARY DATA
    • 15.1.1.1 Key data from secondary sources
  • 15.1.2 PRIMARY DATA
    • 15.1.2.1 Key data from primary sources
    • 15.1.2.2 Key industry insights
• 15.2 MARKET SIZE ESTIMATION
• 15.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 15.4 MARKET RANKING ANALYSIS
• 15.5 STUDY ASSUMPTIONS
• 15.6 RESEARCH LIMITATIONS
  • 15.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 15.6.2 SCOPE-RELATED LIMITATIONS
• 15.7 RISK ASSESSMENT

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS